Social Media Influencers Fueling Parallel Trade for Unlicensed Slimming Medication
An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users administering substances of unknown origin.
Some professionals stated the popularity for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, legal action or prison.
Service Response and Material Elimination
According to the social media company, the service has taken down violative content and prohibited related hashtags and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for preparing or administering at residence.
After minutes of entering one community, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.
Product Details and Costs
Within these groups, posts show dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.
